1Department of Pharmaceutics, Invertis Institute of Pharmacy, Invertis University, Bareilly, U.P.
2Department of Pharmaceutical Chemistry, Invertis Institute of Pharmacy, Invertis University, Bareilly, U.P.
*Corresponding Author: Haribansh Narayan Singh, Department of Pharmaceutical Chemistry, Invertis Institute of Pharmacy, Invertis University, Bareilly, U.P. Email: haribansh1208@gmail.com
Online published on 21 September, 2013.
Pulsatile drug delivery systems are developed to deliver drug in a programmed manner according to circadian behavior of diseases resulting in improved therapeutic efficacy as well as patient compliance These systems are designed for diseases showing chronopharmacological behavior and where the drug dose is required for extended day time or night time activity or for the drugs having high first pass effect or having site specific absorption in GIT, or for drugs with high risk of toxicity. Diseases wherein Pulsatile drug delivery system are likely to be successful for diseases such as asthma, peptic ulcer, cardiovascular diseases, arthritis, hypertension, and hypercholesterolemia. The current article focuses on the review of literature concerning the disease requiring Pulsatile drug delivery system and the drugs used in the pulsatile formulations to target diseases.
